Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma

Otolaryngology - Head and Neck Surgery

Volumn 145, Issue 4, 2011, Pages 586-593

  Brocic, Miroslav ^a   Supic, Gordana ^a   Zeljic, Katarina ^a   Jovic, Nebojsa ^a   Kozomara, Ruzica ^a   Zagorac, Sladjana ^a   Zlatkovic, Milica ^a   Magic, Zvonko ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

ADH1C; Alcohol; CYP2E1; Genetic polymorphisms; Oral cancer risk

Indexed keywords

ALCOHOL DEHYDROGENASE; ALCOHOL DEHYDROGENASE 1C; CYTOCHROME P450 2E1; UNCLASSIFIED DRUG; ADH1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; WILD TYPE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOUTH TUMOR; MULTIVARIATE ANALYSIS; RISK ASSESSMENT;

ALCOHOL DEHYDROGENASE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 84856377930     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811408778     Document Type: Article

References (38)

1. Petti S, Scully C. Oral cancer: the association between nation-based alcohol-drinking profiles and oral cancer mortality. Oral Oncol. 2005;41:828-834. (Pubitemid 41140025)
2. Solomon P, Selvam G, Shanmugam G. Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. Oral Dis. 2008;14:633-639.
3. Supic G, Jovic N, Kozomara R, Zeljic K, Magic Z. Interaction between the MTHFR C677T polymorphism and alcohol: impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res. 2011;90:65-70.
4. Osier M, Pakstis AJ, Soodyall H, et al. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet. 2002;71:84-99. (Pubitemid 34734710)
5. Pares X, Farres J, Pares A, et al. Genetic polymorphism of liver alcohol dehydrogenase in Spanish subjects: significance of alcohol consumption and liver disease. Alcohol Alcohol. 1994;29:701-705.
6. Watanabe J, Hayashi S, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem. 1994;116:321-326. (Pubitemid 24265604)
7. Fritsche E, Pittman G, Bell D. Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene. Mutat Res. 2000;432:1-5. (Pubitemid 30151203)
8. McCarver D, Byun R, Hines R, Hichme M, Wegenek W. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol. 1998;152:276-281. (Pubitemid 28498696)
9. Coutelle C, Ward P, Fleury B, et al. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet. 1997;99:319-325. (Pubitemid 27095791)
10. Harty L, Caporaso N, Hayes R, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst. 1997;89:1698-1705. (Pubitemid 27508194)
11. Brennan P, Lewis S, Hashibe M, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol. 2004;159:1-16. (Pubitemid 38049416)
12. Visapaa JP, Gotte K, Benesova M, et al. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut. 2004;53:871-876. (Pubitemid 38662139)
13. Hashibe M, Boffetta P, Zaridze D, et al. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 2006;15:696-703.
14. Peters E, McClean M, Liu M, Eisen E, Mueller N, Kelsey KT. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev. 2005;14:476-482. (Pubitemid 40270114)
15. Schwartz S, Doody D, Fitzgibbons E, Ricks S, Porter P, Chen C. Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes. Cancer Epidemiol Biomarkers Prev. 2001;10:1137-1144. (Pubitemid 33064301)
16. Kortunay S, Koseler A, Kara C, Topuz B, Atalay E. Frequencies of ADH1C alleles and genotypes in a Turkish head and neck cancer population. Methods Find Exp Clin Pharmacol. 2010;32:187-192.
17. Soucek P, Susova S, Mohelnikova-Duchonova B, et al. Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe. Neoplasma. 2010;57:415-421.
18. Katoh T, Kaneko S, Kohshi K, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer. 1999;83:606-609. (Pubitemid 29508037)
19. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P. Elucidation of CYP2E1 5' regulatory RsaI/PstI allelic variants and their role in risk for oral cancer. Oral Oncol. 2001;37:437-445. (Pubitemid 32480281)
20. Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer. 2000;87:734-740. (Pubitemid 30620418)
21. Wang D, Ritchie JM, Smith EM, Zhang Z, Turek LP, Haugen TH. Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005;14:626-632. (Pubitemid 40489206)
22. Hashibe M, Brennan P, Chuang S, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:541-550.
23. Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD. Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. Pharmacogenetics. 2003;13:501-507. (Pubitemid 37034592)
24. Weiss JR, Baer MR, Ambrosone CB, et al. Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev. 2007;16:1038-1041. (Pubitemid 46910111)
25. Marsh S, Mallon MA, Goodfellow P, McLeod HL. Concordance of pharmacogenetic markers in germline and colorectal tumor DNA. Pharmacogenomics. 2005;6:873-877. (Pubitemid 41724361)
26. Le Marchand L, Wilkinson GR, Wilkens LR. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev. 1999;8:495-500. (Pubitemid 29270332)
27. Groppi A, Begueret J, Iron A. Improved methods for genotype determination of human alcohol dehydrogenase (ADH) at ADH 2 and ADH 3 loci using polymerase chain reaction-directed mutagenesis. Clin Chem. 1990;36:1765-1768.
28. Asakage T, Yokoyama A, Haneda T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis. 2007;28:865-874. (Pubitemid 46523342)
29. Sun F, Tsuritani I, Yamada Y. Contribution of genetic polymorphisms in ethanol-metabolizing enzymes to problem drinking behavior in middle aged Japanese men. Behav Genet. 2002;32:229-236. (Pubitemid 34913073)
30. Kurkivuori J, Salaspuro V, Kaihovaara P, et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol. 2007;43:181-186. (Pubitemid 46176706)
31. Seitz H, Stickel F. Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism. Genes Nutr. 2010;5:121-128.
32. Pöschl G, Seitz H. Alcohol and cancer. Alcohol Alcohol. 2004;39:155-165. (Pubitemid 38578731)
33. Garewal H, Katz V, Meyskens F, et al. Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial. Arch Otolaryngol Head Neck Surg. 1999;125:1305-1310.
34. Larsen S, Vogel U, Christensen J, et al. Interaction between ADH1C Arg272Gln and alcohol intake in relation to breast cancer risk suggests that ethanol is the causal factor in alcohol related breast cancer. Cancer Lett. 2010;295:91-197.
35. Yoo H, Sepkovic D, Bradlow H, Yu G, Sirilian H, Schantz S. Estrogen metabolism as a risk factor for head and neck cancer. Otolaryngol Head Neck Surg. 2001;124:241-247. (Pubitemid 32230512)
36. Cheng YS, Mues G, Wood D, Ding J. Aromatase expression in normal human oral keratinocytes and oral squamous cell carcinoma. Arch Oral Biol. 2006;51:612-620. (Pubitemid 43849638)
37. Pelucchi C, Talamini R, Negri E, et al. Folate intake and risk of oral and pharyngeal cancer. Ann Oncol. 2003;14:1677-1681. (Pubitemid 37455819)
38. Bennett KL, Lee W, Lamarre E, et al. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer. 2010;49:319-326.